APA (7th ed.) Citation

GW, S., MC, T., DS, S., S, J., HF, T., DJ, G., . . . AK, B. (2026). Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis. JCO oncology practice, OP2501241. https://doi.org/10.1200/OP-25-01241

Chicago Style (17th ed.) Citation

GW, Strohbehn, et al. "Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis." JCO Oncology Practice 2026: OP2501241. https://doi.org/10.1200/OP-25-01241.

MLA (9th ed.) Citation

GW, Strohbehn, et al. "Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis." JCO Oncology Practice, 2026, p. OP2501241, https://doi.org/10.1200/OP-25-01241.